Elsevier Health introduces Sherpath AI to address challenges facing US nursing education

Elsevier Health, a global leader in information and analytics, today introduced Sherpath AI, the most advanced generative AI chat designed specifically for nursing students. The tool integrates Elsevier's trusted nursing education content with advanced generative artificial intelligence (Gen AI), offering a beneficial aid for students and nurse educators navigating courses, exam preparation, and the transition into clinical practice.

The use of AI in healthcare education is expected to grow considerably in the next 2-3 years. In Elsevier’s Clinician of the Future 2023: Education report 新しいタブ／ウィンドウで開く it was found that 62% of students are excited by the prospect of using generative AI tools in their education. The early feedback from students and educators who have tested Sherpath AI suggests the tool will enhance the learning experience for students and improve results.

With Sherpath AI, nursing students can ask questions with natural language in the same way they would speak to a trusted tutor or expert. The tool provides verified nursing education content, source citations for accuracy and reliability, diverse multimedia tutorials, interactive dialogue and personalized responses. Underpinning the content and technology are Elsevier's Responsible AI Principles 新しいタブ／ウィンドウで開く and Privacy Principles 新しいタブ／ウィンドウで開く created in collaboration with our communities.

Brent Gordon, President, Nursing & Health Education, Elsevier Health said: “We are optimistic about the promise of generative AI to expand personalized learning, improve program outcomes, and extend the reach of our trusted institutional partners to train more practice-ready nurses. We are grateful to the students and educators who are working closely with us during Sherpath AI's phased development and testing and we are excited about the national roll-out later this year.”

Sherpath AI offers best-in-class features including:

• trusted nursing education content

• source citations for accuracy and reliability

• diverse multi-media tutorials like Osmosis for Nursing videos

• interactive chat dialogue and personalized responses in the moment of learning

• support for course preparation and teaching strategies

Judith Karshmer Ph.D, MSN, MS, RN, Dean of the Edson College of Nursing and Health Innovation, Arizona State University said: “At Arizona State University, we are seeking innovative ways to enhance student success and broaden access to nursing education. Especially as we prepare to launch ASU Health, the potential for generative AI to transform learning and teaching is immense, and we're optimistic about how Sherpath AI can support our goals. We see how Sherpath AI can help students succeed in their studies, NCLEX prep, and preparation for practice, and are thrilled that our students will have an opportunity to experience it and share their feedback.”

Janelle R. Sokolowich Ph.D., MSN/Ed.RN, Associate Provost, Chamberlain University said: “Sherpath AI supports faculty in developing alternative teaching strategies. The feature allows faculty to ask for innovative methods to teach specific content. It can serve as a guide for novice faculty members as well as experienced faculty members who want to uncover alternative methods to support learning. The value is that faculty will be confident in their student’s use of the product knowing the resources are verified and accurate. The ability to have students and faculty use AI in a controlled environment is dynamic.”

Sherpath AI builds on Sherpath, Elsevier's market-leading teaching and learning courseware platform that supports hundreds of thousands of nursing students across the US, preparing them for both the National Council Licensure Examination (NCLEX) exam and clinical practice. The introduction of generative AI into its offerings aims to streamline access to trustworthy information, facilitating the education of the next generation of healthcare professionals.

For over two decades, Elsevier has combined AI and machine learning technologies with trusted, evidence-based content and extensive data sets to create effective solutions for the education, research, life sciences, and healthcare sectors. The launch of Sherpath AI is a significant step forward in the company’s commitment to leveraging technology to make learning more accessible, personalized, and effective. With the emergence of generative AI, there is so much potential for useful applications, and Elsevier Health is committed to harnessing this technology to improve educational outcomes.

To learn more about Sherpath AI and register to be a part of the exclusive Sherpath AI preview experience for Fall 2024, please visit our website by clicking here 新しいタブ／ウィンドウで開く.

About Elsevier Health

For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence–based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.

Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide; we bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.

エルゼビアについて エルゼビアは、科学情報と分析を牽引するグローバル企業として、研究者や医療従事者が社会の利益のために科学を進歩させ、医療成果を向上させることを支援しています。我々は信頼できるエビデンスベースのコンテンツと高度なAI対応デジタルテクノロジーに基づくソリューションにより、インサイトと重要な意思決定を促進することでこれを実現しています。

エルゼビアは、140 年以上にわたり研究および医療コミュニティの活動を支援してきました。全世界で 2,500 人以上の技術者を含む 9,500 人の従業員がおり、重要な職務における研究者や、図書館員、アカデミックリーダー、資金提供者、政府機関、R&D 関連企業、医師、看護師、将来の医療従事者や教育者を支援することに従事してきました。2,900 誌以上の科学ジャーナルと代表的な参考文献には、Cell Press、The Lancet、Gray's Anatomy など、各分野の主要なタイトルを含みます。 エルゼビア・ファウンデーション 新しいタブ／ウィンドウで開くと共に、開発途上国および世界中の科学、研究、医療分野におけるインクルージョン＆ダイバーシティ 新しいタブ／ウィンドウで開くを推進するため、支援コミュニティと連携して活動しています。 エルゼビアは、プロフェッショナルおよびビジネス顧客向けの情報に基づく分析および意思決定ツールのグローバルプロバイダーである RELX 新しいタブ／ウィンドウで開くグループの一部です。業務内容やデジタルソリューション、コンテンツ詳細については、 www.elsevier.com/ja-jpをご参照ください。